⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6902189 | 0.76 | — | — | |
| SCHEMBL14854005 | 0.74 | — | — | |
| SCHEMBL2037213 | 0.74 | — | — | |
| SCHEMBL6527809 | 0.74 | ALDH1A1 (0.37) | — | |
| SCHEMBL12641920 | 0.72 | TLR8 (0.43) | — | |
| SCHEMBL20059589 | 0.71 | — | — | |
| SCHEMBL17260752 | 0.69 | BRD4 (0.37) | — | |
| SCHEMBL18292609 | 0.69 | HDAC8 (0.33) | — | |
| SCHEMBL5410816 | 0.69 | — | — | |
| SCHEMBL17768868 | 0.69 | PTGS2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9982020-B2 | Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2018-05-29 | — | — | US | claimed |
| CN-104024247-B | Be useful on treatment human papilloma virus's the polyamide being replaced by guanidine radicals | NANOVIR LLC (US) | 2016-05-25 | — | — | CN | claimed |
| US-9333232-B2 | Methods for treating papilloma virus infection | NANOVIR LLC (US) | 2016-05-10 | — | — | US | claimed |
| US-9290551-B2 | Compounds for treating papilloma virus infection | NANOVIR LLC (US) | 2016-03-22 | — | — | US | claimed |
| WO-2016022664-A1 | ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING INFECTIONS CAUSED BY DOUBLE-STRANDED DNA VIRUSES | NANOVIR LLC (US) | 2016-02-11 | — | — | WO | claimed |
| US-20150329596-A1 | ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING INFECTIONS CAUSED BY DOUBLE-STRANDED DNA VIRUSES | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2015-11-19 | — | — | US | claimed |
| US-9133228-B2 | Guanidinyl-substituted polyamides useful for treating human papilloma virus | NANOVIR LLC (US) | 2015-09-15 | — | — | US | claimed |
| US-20150239943-A1 | COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2015-08-27 | — | — | US | claimed |
| US-8993609-B2 | Compounds for treating papilloma virus infection | NANOVIR, LLC (US) | 2015-03-31 | — | — | US | claimed |
| EP-2751096-A2 | GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS | Nanovir, LLC (US) | 2014-07-09 | — | — | EP | claimed |
| WO-2014065848-A2 | COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION | BASHKIN JAMES K (US) | 2014-05-01 | — | — | WO | claimed |
| WO-2013055825-A2 | GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2013-04-18 | — | — | WO | claimed |
| US-20130090362-A1 | GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2013-04-11 | — | — | US | claimed |
| US-20120225809-A1 | COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION | NANOVIR, LLC (US) | 2012-09-06 | — | — | US | claimed |
| US-8119677-B2 | Polyamides containing amino butyric acid-based building blocks | NANOVIR, LLC (US) | 2012-02-21 | — | — | US | claimed |
| EP-2013200-A2 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | Nanovir, LLC (US) | 2009-01-14 | — | — | EP | claimed |
| US-20070293417-A1 | Polyamides for treating human papilloma virus | NANOVIR, LLC | 2007-12-20 | — | — | US | claimed |
| WO-2007130616-A2 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2007-11-15 | — | — | WO | claimed |
| WO-2007103584-A2 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2007-09-13 | — | — | WO | claimed |
| US-9982020-B2 | Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2018-05-29 | — | — | US | disclosed |
| EP-3100745-A1 | NOVEL BENZODIAZEPINE DERIVATIVES | Immunogen, Inc. (US) | 2016-12-07 | — | — | EP | disclosed |
| CN-104024247-B | Be useful on treatment human papilloma virus's the polyamide being replaced by guanidine radicals | NANOVIR LLC (US) | 2016-05-25 | — | — | CN | disclosed |
| US-9333232-B2 | Methods for treating papilloma virus infection | NANOVIR LLC (US) | 2016-05-10 | — | — | US | disclosed |
| US-9290551-B2 | Compounds for treating papilloma virus infection | NANOVIR LLC (US) | 2016-03-22 | — | — | US | disclosed |
| WO-2016022664-A1 | ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING INFECTIONS CAUSED BY DOUBLE-STRANDED DNA VIRUSES | NANOVIR LLC (US) | 2016-02-11 | — | — | WO | disclosed |
| US-20150329596-A1 | ANTIVIRAL COMPOUNDS AND METHODS FOR TREATING INFECTIONS CAUSED BY DOUBLE-STRANDED DNA VIRUSES | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2015-11-19 | — | — | US | disclosed |
| US-9133228-B2 | Guanidinyl-substituted polyamides useful for treating human papilloma virus | NANOVIR LLC (US) | 2015-09-15 | — | — | US | disclosed |
| US-20150239943-A1 | COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2015-08-27 | — | — | US | disclosed |
| US-8993609-B2 | Compounds for treating papilloma virus infection | NANOVIR, LLC (US) | 2015-03-31 | — | — | US | disclosed |
| EP-2751096-A2 | GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS | Nanovir, LLC (US) | 2014-07-09 | — | — | EP | disclosed |
| WO-2014065848-A2 | COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION | BASHKIN JAMES K (US) | 2014-05-01 | — | — | WO | disclosed |
| WO-2013055825-A2 | GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2013-04-18 | — | — | WO | disclosed |
| US-20130090362-A1 | GUANIDINYL-SUBSTITUTED POLYAMIDES USEFUL FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2013-04-11 | — | — | US | disclosed |
| US-20120225809-A1 | COMPOUNDS FOR TREATING PAPILLOMA VIRUS INFECTION | NANOVIR, LLC (US) | 2012-09-06 | — | — | US | disclosed |
| EP-2013200-B1 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR LLC (US) | 2012-04-25 | — | — | EP | disclosed |
| US-8119677-B2 | Polyamides containing amino butyric acid-based building blocks | NANOVIR, LLC (US) | 2012-02-21 | — | — | US | disclosed |
| US-20100015084-A1 | Compounds for Treating Papilloma Virus Infection | NANOVIR, LLC (US) | 2010-01-21 | — | — | US | disclosed |
| US-20090306164-A1 | Methods for Treating Papilloma Virus Infection | NANOVIR, LLC (US) | 2009-12-10 | — | — | US | disclosed |
| US-7589171-B2 | Polyamides for treating human papilloma virus | NANOVIR, LLC (US) | 2009-09-15 | — | — | US | disclosed |
| EP-2013200-A2 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | Nanovir, LLC (US) | 2009-01-14 | — | — | EP | disclosed |
| US-20070293417-A1 | Polyamides for treating human papilloma virus | NANOVIR, LLC | 2007-12-20 | — | — | US | disclosed |
| WO-2007130616-A2 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007103584-A2 | POLYAMIDES FOR TREATING HUMAN PAPILLOMA VIRUS | NANOVIR, LLC (US) | 2007-09-13 | — | — | WO | disclosed |
| EP-1442022-A4 | POLYAMIDE MODULATORS OF COX2 TRANSCRIPTION | PHARMACIA CORP (US) | 2005-05-04 | — | — | EP | disclosed |
| WO-2005033282-A2 | POLYAMIDE COMPOSITIONS AND THERAPEUTIC METHODS FOR TREATMENT OF HUMAN PAPILLOMA VIRUS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2005-04-14 | — | — | WO | disclosed |
| EP-1442022-A2 | POLYAMIDE MODULATORS OF COX2 TRANSCRIPTION | Pharmacia Corporation (US) | 2004-08-04 | — | — | EP | disclosed |
| US-20030119891-A1 | Polyamide modulators of COX2 transcription | PHARMACIA CORPORATION | 2003-06-26 | — | — | US | disclosed |
| WO-2003040337-A2 | POLYAMIDE MODULATORS OF COX2 TRANSCRIPTION | PHARMACIA CORPORATION (US) | 2003-05-15 | — | — | WO | disclosed |
| WO-2003040337-A2 | POLYAMIDE MODULATORS OF COX2 TRANSCRIPTION | PHARMACIA CORPORATION (US) | 2003-05-15 | — | — | WO | disclosed |